三金SANJIN品牌怎么样 申请店铺

我要投票 三金SANJIN在口气清新剂行业中的票数:931 更新时间:2025-12-23
三金SANJIN是哪个国家的品牌?「三金SANJIN」是 桂林三金药业股份有限公司 旗下著名品牌。该品牌发源于广西,由创始人邹节明在1994期间创立,经过多年的不懈努力和高速发展,现已成为行业的标杆品牌。

外推网助力三金SANJIN品牌出海!将品牌入驻外推网,定制三金SANJIN品牌推广信息,可以显著提高三金SANJIN产品曝光,简直是跨境电商爆单神器!目前仅需1000元/年哦~

三金SANJIN怎么样

桂林三金药业股份有限公司是三金集团的核心企业,主营中成药、天然药物的研发和生产,是国内较早生产现代中药制剂的厂家之一,也是广西医药龙头企业。1985年以来,桂林三金坚持改革创新,依靠科技进步和科学管理,从一个名不见经传的中药作坊小厂蜕变成为全国知名的现代中药企业。

三金作为区内外知名的高新技术企业,建有国家认定的企业技术中心、博士后科研工作站及广西中药产业化工程院等创新平台。多年来,一直致力推进和实施中药产业现代化规划,积极培养、提高企业的自主创新能力。目前公司的特色中药新药均由企业技术中心主导研制。目前,三金拥有200多个注册品种和13个药品剂型,拥有桂林西瓜霜、西瓜霜润喉片、三金片、脑脉泰胶囊等自主开发的特色品种42种。经过多年努力,三金在咽喉、口腔用药和泌尿系统用药方面已形成较强的专业和市场优势,代表产品三金西瓜霜系列、三金片。“三金”牌产品已行销海内外,并享有良好声誉。

2009年7月,桂林三金以高成长、高效益的崭新面貌,成功进入资本市场,迎来企业高速发展的新阶段。近年来,为积极响应桂林市委、市政府“向西发展,再造一个新桂林”的号召,也为解决企业生产基地及仓储设施分散与企业快速发展之间的矛盾,三金启动了“三金现代中药产业化技术改造工程”的建设。目前,该项目一期已经正式投产并实现了主要生产线的整体搬迁。

面对未来,三金将秉承“创新推动医药进步”的企业使命和“敢为先”企业精神,实施以中药制药为主体,致力发展生物制药和大健康产业的”一体两翼”发展战略,视质量、信誉为企业第一生命,突破创新,不断增强三金的竞争实力,锐意进取,以发展报国、回报投资者,以打造中国知名医药制造集团为目标,推动中药产业现代化、国际化!


Guilin Sanjin Pharmaceutical Co., Ltd. is the core enterprise of Sanjin group, which is mainly engaged in the research and development and production of Chinese patent medicine and natural medicine. It is one of the earliest manufacturers of modern Chinese medicine preparations in China, and also the leading enterprise of Guangxi medicine. Since 1985, Guilin Sanjin has persisted in reform and innovation, relying on scientific and technological progress and scientific management, and has transformed from an unknown small traditional Chinese medicine workshop into a well-known modern Chinese medicine enterprise in China. As a well-known high-tech enterprise inside and outside the zone, Sanjin has established a national recognized enterprise technology center, postdoctoral research workstation, Guangxi Institute of traditional Chinese medicine industrialization and other innovation platforms. Over the years, we have been committed to promoting and implementing the modernization plan of traditional Chinese medicine industry, and actively cultivating and improving the independent innovation ability of enterprises. At present, the company's characteristic new Chinese medicine is mainly developed by the enterprise technology center. At present, Sanjin has more than 200 registered varieties and 13 pharmaceutical dosage forms, and 42 self-developed characteristic varieties such as Guilin Watermelon cream, watermelon cream throat moistening tablet, Sanjin tablet, Naomaitai Capsule, etc. After years of efforts, Sanjin has formed strong professional and market advantages in throat, oral medicine and urinary system medicine, representing Sanjin watermelon cream series and Sanjin tablets. "Three gold" brand products have been sold at home and abroad, and enjoy a good reputation. In July 2009, Guilin Sanjin successfully entered the capital market and ushered in a new stage of rapid development of enterprises with a new look of high growth and high efficiency. In recent years, in order to actively respond to the call of Guilin municipal Party committee and municipal government to "develop to the West and rebuild a new Guilin", and to solve the contradiction between the scattered production base and storage facilities of enterprises and the rapid development of enterprises, Sanjin has launched the construction of "Sanjin modern Chinese medicine industrialization technology transformation project". At present, the first phase of the project has been officially put into operation and the overall relocation of the main production lines has been realized. In the future, Sanjin will adhere to the enterprise mission of "innovation promotes pharmaceutical progress" and the enterprise spirit of "dare to be the first", implement the development strategy of "one body and two wings" with traditional Chinese medicine as the main body, devote to the development of biopharmaceutical and big health industry, regard quality and reputation as the life of the enterprise, break through innovation, continuously enhance the competitiveness of Sanjin, forge ahead, serve the country and return with development Newspaper investors, with the goal of building a well-known Chinese pharmaceutical manufacturing group, to promote the modernization and internationalization of traditional Chinese medicine industry!

本文链接: https://brand.waitui.com/7e6028fbc.html 联系电话:请联系客服添加 联系邮箱:请联系客服添加

外推网广告位招租,每天只要9块9

7×24h 快讯

启境首款车开启大规模路测

12月22日,启境首款车开启大规模路测。据了解,该车定位猎装轿跑,将搭载华为乾崑智能汽车解决方案。目前,该车已进入全国多环境路测阶段,预计将在零下30度的极寒、40度以上的高温以及高海拔等多重场景中完成全方位严苛测试,覆盖极寒冰面、高温湿热、高原等环境,重点验证底盘操控、智驾安全、座舱舒适、车身防腐、碰撞安全及NVH静谧性等全方位性能。

2小时前

美股大型科技股盘前普涨,美光科技涨近4%

36氪获悉,美股大型科技股盘前普涨,截至发稿,美光科技涨近4%,英伟达、特斯拉、英特尔涨超1%,谷歌涨0.66%,奈飞涨0.56%,亚马逊涨0.48%,Meta涨0.45%,微软涨0.32%,苹果跌0.16%。

2小时前

热门中概股美股盘前集体走强,拼多多涨超2%

36氪获悉,热门中概股美股盘前集体走强,截至发稿,拼多多涨超2%,小鹏汽车涨0.76%,蔚来涨0.6%,百度涨0.46%,哔哩哔哩涨0.28%,京东涨0.24%,阿里巴巴涨0.23%,理想汽车跌0.06%。

2小时前

潍柴雷沃智慧农业科技股份有限公司向港交所提交上市申请书

36氪获悉,港交所文件显示,潍柴雷沃智慧农业科技股份有限公司向港交所提交上市申请书,独家保荐人为中金公司。

2小时前

祥源文旅:实际控制人俞发祥因涉嫌犯罪被采取刑事强制措施

36氪获悉,祥源文旅公告,公司实际控制人俞发祥因涉嫌犯罪被绍兴市公安局采取刑事强制措施,案件正在调查过程中。截至公告披露日,公司未收到有关机关要求公司协助调查的通知,公司控制权未发生变化。俞发祥未在公司担任任何职务,公司生产经营一切正常,上述事项不会对公司正常生产经营产生重大影响。

2小时前

本页详细列出关于三金SANJIN的品牌信息,含品牌所属公司介绍,三金SANJIN所处行业的品牌地位及优势。
咨询